Isofol Medical AB (5IU) Stock Statistics & Valuation Metrics

Isofol Medical AB has a market cap or net worth of €25.60M. The enterprise value is €262.41M.

Isofol Medical AB has 161,515,440 shares outstanding. The number of shares has decreased by -2.65% in one year.

Isofol Medical AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Isofol Medical AB is -3.17. Isofol Medical AB’s PEG ratio is 0.04.

In the last 12 months, Isofol Medical AB had revenue of 721.00K and earned -37.07M in profits. Earnings per share was -0.23.

In the last 12 months, operating cash flow was -41.99M and capital expenditures 0.00, giving a free cash flow of -41.99M billion.

Isofol Medical AB pays an annual dividend of €0.069, resulting in a dividend yield of ―

Isofol Medical AB upcoming earnings date is May 21, 2025, TBA Not Confirmed.

Isofol Medical AB as a current ratio of 7.70, with Debt / Equity ratio of 0.00%

In the past 12 months, Isofol Medical AB has paid 0.00 in taxes.

Isofol Medical AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Isofol Medical AB has €96.16M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€96.16M billion.

Gross margin is 0.00%, with operating margin of -5781.28%, and net profit margin of -5141.61%.

The average price target for Isofol Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―